
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName archivearticle.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">J Cell Biol</journal-id><journal-id journal-id-type="iso-abbrev">J. Cell Biol</journal-id><journal-title-group><journal-title>The Journal of Cell Biology</journal-title></journal-title-group><issn pub-type="ppub">0021-9525</issn><issn pub-type="epub">1540-8140</issn><publisher><publisher-name>The Rockefeller University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">2195993</article-id><article-id pub-id-type="publisher-id">0010103</article-id><article-id pub-id-type="pmid">11157990</article-id><article-categories><subj-group subj-group-type="heading"><subject>Report</subject></subj-group></article-categories><title-group><article-title><SecTag type="TITLE"><text><SENT sid="0" pm="."><plain>An Inducible Mouse Model for Epidermolysis Bullosa Simplex </plain></SENT>
</text></SecTag></article-title><subtitle>Implications for Gene Therapy</subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Cao</surname><given-names>Tongyu</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Longley</surname><given-names>Mary Ann</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Xiao-Jing</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref></contrib><contrib contrib-type="author"><name><surname>Roop</surname><given-names>Dennis R.</given-names></name><address><addr-line>Department of Molecular and Cellular Biology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030.</addr-line><fax>(713)798-3800</fax><phone>(713)798-4966</phone></address><email>roopd@bcm.tmc.edu</email><xref ref-type="aff" rid="a">a</xref><xref ref-type="aff" rid="b">b</xref></contrib><aff id="a">
<label>a</label>Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030</aff><aff id="b">
<label>b</label>Department of Dermatology, Baylor College of Medicine, Houston, Texas 77030</aff></contrib-group><pub-date pub-type="ppub"><day>5</day><month>2</month><year>2001</year></pub-date><volume>152</volume><issue>3</issue><fpage>651</fpage><lpage>656</lpage><history><date date-type="received"><day>23</day><month>10</month><year>2000</year></date><date date-type="rev-request"><day>22</day><month>12</month><year>2000</year></date><date date-type="accepted"><day>29</day><month>12</month><year>2000</year></date></history><permissions><copyright-statement>© 2001 The Rockefeller University Press</copyright-statement><copyright-year>2001</copyright-year><copyright-holder>The Rockefeller University Press</copyright-holder><license license-type="openaccess"><license-p>This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see <ext-link ext-link-type="uri" xlink:href="http://www.rupress.org/terms">http://www.rupress.org/terms</ext-link>). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0/">http://creativecommons.org/licenses/by-nc-sa/4.0/</ext-link>).</license-p></license></permissions><abstract><p><SecTag type="ABS"><text><SENT sid="1" pm="."><plain>The Dowling-Meara variant of epidermolysis bullosa simplex (EBS-DM) is a severe blistering disease inherited in an autosomal-dominant fashion. </plain></SENT>
<SENT sid="2" pm="."><plain>Here we report the generation of a mouse model that allows focal activation of a mutant keratin 14 allele in epidermal stem cells upon topical administration of an inducer, resulting in EBS phenotypes in treated areas. </plain></SENT>
<SENT sid="3" pm="."><plain>Using laser capture microdissection, we show that induced blisters healed by migration of surrounding nonphenotypic stem cells into the wound bed. </plain></SENT>
<SENT sid="4" pm="."><plain>This observation provides an explanation for the lack of mosaic forms of EBS-DM. </plain></SENT>
<SENT sid="5" pm="."><plain>In addition, we show that decreased mutant keratin 14 expression resulted in normal morphology and functions of the skin. </plain></SENT>
<SENT sid="6" pm="."><plain>Our results have important implications for gene therapy of EBS and other dominantly inherited diseases. </plain></SENT>
</text></SecTag></p></abstract><SecTag type="KEYWORD"><kwd-group><kwd>epidermolysis bullosa simplex</kwd><kwd>gene therapy</kwd><kwd>gene targeting</kwd><kwd>epidermal stem cells</kwd><kwd>keratins</kwd></kwd-group></SecTag></article-meta></front><body><SecTag type="INTRO"><sec><title><text><SENT sid="7" pm="."><plain>Introduction </plain></SENT>
</text></title><p><text><SENT sid="8" pm="."><plain>The primary function of the epidermis is to provide a protective barrier for the internal tissues and organs. </plain></SENT>
<SENT sid="9" pm="."><plain>The structural integrity of epidermal keratinocytes is maintained by a filamentous network made up of keratins, which belong to the intermediate filament (IF) protein superfamily (Moll et al. </plain></SENT>
<SENT sid="10" pm="."><plain>1982; Quinlan et al. </plain></SENT>
<SENT sid="11" pm="."><plain>1985). </plain></SENT>
<SENT sid="12" pm="."><plain>Two types of keratin subunits have been described. </plain></SENT>
<SENT sid="13" pm="."><plain>In general, type I keratin subunits are smaller, with an acidic pI, and are encoded by genes located on chromosome 17 (Quinlan et al. </plain></SENT>
<SENT sid="14" pm="."><plain>1985). </plain></SENT>
<SENT sid="15" pm="."><plain>Type II keratin subunits are larger and more basic, and are encoded by genes located on chromosome 12 (Quinlan et al. </plain></SENT>
<SENT sid="16" pm="."><plain>1985). </plain></SENT>
</text></p><p><text><SENT sid="17" pm="."><plain>The basic structure of keratins is an α-helical rod domain made up of repeating units of seven amino acids. </plain></SENT>
<SENT sid="18" pm="."><plain>One member of each type of keratins is needed to form a heterodimer through the rod domain, which then assembles into higher order structures to form mature keratin filaments (Hatzfeld and Weber 1990; Steinert 1990; Rothnagel and Roop 1995). </plain></SENT>
<SENT sid="19" pm="."><plain>The α-helical rod domain is not continuous but is made up of four helical segments, termed 1A, 1B, 2A, and 2B (Steinert and Roop 1988). </plain></SENT>
<SENT sid="20" pm="."><plain>The beginning of 1A and the end of 2B overlap with the neighboring keratin molecules and are crucial for the stability of the keratin filaments (Rothnagel and Roop 1995). </plain></SENT>
<SENT sid="21" pm="."><plain>Mutations in these regions of keratin genes have been identified in patients with epidermolysis bullosa simplex (EBS) and epidermolytic hyperkeratosis (EHK) (Rothnagel and Roop 1995). </plain></SENT>
</text></p><p><text><SENT sid="22" pm="."><plain>The Dowling-Meara variant of EBS (EBS-DM, or EB Herpetiformis, MIM No. 131760) is the most severe form of EBS, and it is inherited in an autosomal-dominant fashion. </plain></SENT>
<SENT sid="23" pm="."><plain>At birth, it presents with generalized blisters in areas prone to mechanical trauma (Dowling and Meara 1954; Marinkovich et al. </plain></SENT>
<SENT sid="24" pm="."><plain>1999). </plain></SENT>
<SENT sid="25" pm="."><plain>The underlying mechanism of basal cell lysis is the disintegration of the IF network and the formation of perinuclear keratin clumps (Anton-Lamprecht and Schnyder 1982; McGrath et al. </plain></SENT>
<SENT sid="26" pm="."><plain>1992). </plain></SENT>
<SENT sid="27" pm="."><plain>EBS-DM has been linked to chromosomes 12 and 17, and mutations in keratin 5 (K5) and keratin 14 (K14) genes expressed in basal keratinocytes have been identified in these patients (Letai et al. </plain></SENT>
<SENT sid="28" pm="."><plain>1993; Chen et al. </plain></SENT>
<SENT sid="29" pm="."><plain>1995; Rothnagel and Roop 1995). </plain></SENT>
<SENT sid="30" pm="."><plain>In addition, a mutational “hot spot” at codon 125 resulting in the change of an arginine in the 1A region of the K14 rod domain was found in 70% of EBS-DM patients (Rothnagel and Roop 1995). </plain></SENT>
</text></p><p><text><SENT sid="31" pm="."><plain>Two mouse models were previously generated for EBS (Vassar et al. </plain></SENT>
<SENT sid="32" pm="."><plain>1991; Lloyd et al. </plain></SENT>
<SENT sid="33" pm="."><plain>1995). </plain></SENT>
<SENT sid="34" pm="."><plain>Both exhibited EBS-like phenotypes, but neither mimicked the dominantly inherited disease at the genetic level. </plain></SENT>
<SENT sid="35" pm="."><plain>To test gene therapy approaches for EBS, it is necessary to generate a mouse model that mimics EBS at both the genetic and phenotypic levels. </plain></SENT>
<SENT sid="36" pm="."><plain>In this study, we generated a mouse model that fulfills these criteria. </plain></SENT>
<SENT sid="37" pm="."><plain>To elucidate the involvement of epidermal stem cells, we also developed a mouse model that allowed focal induction of EBS phenotypes. </plain></SENT>
</text></p></sec></SecTag><SecTag type="METHODS"><sec sec-type="materials|methods"><title><text><SENT sid="38" pm="."><plain>Materials and Methods </plain></SENT>
</text></title><sec><title><text><SENT sid="39" pm="."><plain>Construction of the Targeting Vector </plain></SENT>
</text></title><p><text><SENT sid="40" pm="."><plain>A genomic clone containing the mouse K14 gene in bacterial phage P1 was isolated from a 129/SVJ genomic library (Incyte Genomics). </plain></SENT>
<SENT sid="41" pm="."><plain>A C→T point mutation at codon 131 (resulting in an arginine to cysteine substitution) in mouse K14 was engineered in a 1.3-kb BamHI fragment by PCR, which was then used to replace the wild-type BamHI fragment in the gene. </plain></SENT>
<SENT sid="42" pm="."><plain>For the selection of recombinant embryonic stem (ES) cells, a neomycin-resistance (neo) cassette flanked by loxP sites (a gift from R.R. </plain></SENT>
<SENT sid="43" pm="."><plain>Behringer and Y. </plain></SENT>
<SENT sid="44" pm="."><plain>Mishina, University of Texas, M.D. </plain></SENT>
<SENT sid="45" pm="."><plain>Anderson Cancer Center, Houston, TX) was inserted into the PmlI site in intron I of the mutant K14 gene. </plain></SENT>
<SENT sid="46" pm="."><plain>This insertion also introduced an EcoRV restriction site that allowed us to identify homologous recombination by Southern blot analysis. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="47" pm="."><plain>Generation of mtK14neo and mtK14loxP Mice </plain></SENT>
</text></title><p><text><SENT sid="48" pm="."><plain>Mouse 129/SVJ ES cells (Incyte Genomics) were electroporated with the linearized targeting vector, and homologous recombination in ES cell clones was identified by Southern blot analysis of genomic DNA digested with Eco RV. </plain></SENT>
<SENT sid="49" pm="."><plain>The presence of the C→T mutation was confirmed by sequence analysis. </plain></SENT>
<SENT sid="50" pm="."><plain>Recombinant ES cells (mtK14neo) were injected into C57BL/6 blastocysts. </plain></SENT>
<SENT sid="51" pm="."><plain>Three independent mtK14neo mouse lines were generated, and were phenotypically indistinguishable. </plain></SENT>
<SENT sid="52" pm="."><plain>The mtK14neo ES cells were also transfected with a CMV-Cre plasmid (a gift from S. </plain></SENT>
<SENT sid="53" pm="."><plain>O'Gorman, The Salk Institute for Biological Studies, San Diego, CA), and cells without the neo cassette (mtK14loxP) were injected into blastocysts as well. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="54" pm="."><plain>RNA Preparation and Semi-quantitative RT-PCR Analysis </plain></SENT>
</text></title><p><text><SENT sid="55" pm="."><plain>Total RNA from newborn pup epidermis was isolated using RNAzol B (Tel-Test). </plain></SENT>
<SENT sid="56" pm="."><plain>Equal amounts of total RNA from epidermal samples were reverse transcribed into cDNA. </plain></SENT>
<SENT sid="57" pm="."><plain>The cDNA was amplified by semi-quantitative PCR using K14-specific primers: 5′-CTAGCCGCATGTCCTCCATC-3′ and 5′-biotin-CCGAATCTTCACCTCCAGTTC-3′. </plain></SENT>
<SENT sid="58" pm="."><plain>PCR products were gel purified and digested with AciI (New England Biolabs, Inc.). </plain></SENT>
<SENT sid="59" pm="."><plain>Digestion of the wild-type PCR products yielded a 71-bp biotinylated fragment. </plain></SENT>
<SENT sid="60" pm="."><plain>The C→T mutation destroyed an AciI site, resulting in a 136-bp biotinylated fragment from the mutant PCR products. </plain></SENT>
<SENT sid="61" pm="."><plain>Digested DNA fragments were separated by gel electrophoresis, blotted onto GeneScreenPlus membrane (New England Biolabs, Inc.), and detected with BrightStar BioDetect kit (Ambion). </plain></SENT>
<SENT sid="62" pm="."><plain>The intensity of the signals was determined by QuantiScan software (Biosoft). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="63" pm="."><plain>Immunofluorescence Microscopy and Transmission Electron Microscopy </plain></SENT>
</text></title><p><text><SENT sid="64" pm="."><plain>Biopsied skin was fixed in 10% Formalin (Fisher Scientific) or embedded in OCT (Sakura Finetek USA), and indirect immunofluorescent staining of sections was performed as previously described (Wojcik et al. </plain></SENT>
<SENT sid="65" pm="."><plain>2000), using a guinea pig anti-K14 antibody, a rabbit anti-K10 antibody, a rabbit anti-loricrin antibody, and a rat anti-integrin α6 antibody (Chemicon) (Wang et al. </plain></SENT>
<SENT sid="66" pm="."><plain>1995). </plain></SENT>
<SENT sid="67" pm="."><plain>The anti-K14 antibody recognized both wild-type and mutant mouse K14. </plain></SENT>
<SENT sid="68" pm="."><plain>Transmission electron microscopy was carried out following standard protocol (Wang et al. </plain></SENT>
<SENT sid="69" pm="."><plain>1995). </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="70" pm="."><plain>Laser Capture Microdissection </plain></SENT>
</text></title><p><text><SENT sid="71" pm="."><plain>Biopsied skin from healed blistered area on the palm of RU486 treated mtK14neo/CrePR1 pups was fixed in 10% Formalin and embedded in paraffin (Wojcik et al. </plain></SENT>
<SENT sid="72" pm="."><plain>2000). </plain></SENT>
<SENT sid="73" pm="."><plain>Paraffin slides were stained with Nuclear Fast Red (Vector Laboratories), and epidermal cells under the scab were transferred onto a thermoplastic polymer film (CapSure™) by a near infrared laser pulse on a PixCell I microscope/laser capture equipment (Arcturus Engineering). </plain></SENT>
<SENT sid="74" pm="."><plain>Genomic DNA was extracted from cells attached to the film in 10 mM Tris-HCl (pH 8.0), 0.2 mM EDTA (pH 8.0), 0.25% Tween 20, and 0.5% Nonidet P-40 containing 1 mg/ml proteinase K. </plain></SENT>
<SENT sid="75" pm="."><plain>DNA was then analyzed by PCR. </plain></SENT>
<SENT sid="76" pm="."><plain>For the presence of the loxP site, primers 5′-GAACTGGAGGTGAAGATTCG-3′ (in exon I of K14) and 5′-GGGTTATTGAATATGATCGG-3′ (in the loxP site) were used. </plain></SENT>
<SENT sid="77" pm="."><plain>For the presence of the neo cassette, primers 5′-GCGGAACCCTTAATATAACT-3′ (in the linker region of the neo cassette) and 5′-CCACACAGTCAGCTTCAACC-3′ (in intron I of K14) were used. </plain></SENT>
</text></p></sec></sec></SecTag><SecTag type="RESULTS,DISCUSS"><sec><title><text><SENT sid="78" pm="."><plain>Results and Discussion </plain></SENT>
</text></title><sec><title><text><SENT sid="79" pm="."><plain>Characterization of mtK14neo Mice </plain></SENT>
</text></title><p><text><SENT sid="80" pm="."><plain>To generate a mouse model that mimics EBS-DM at the genetic level, we introduced a point mutation in codon 131 (equivalent to arginine 125 in human K14) of the mouse K14 gene. </plain></SENT>
<SENT sid="81" pm="."><plain>The gene targeting vector used to introduce this mutation into ES cells also contained a neo cassette in intron I (Fig. 1 A). </plain></SENT>
<SENT sid="82" pm="."><plain>The linearized targeting vector was electroporated into ES cells, and homologous recombination was identified by Southern blot analysis of genomic DNA from these cells (Fig. 1 B). </plain></SENT>
<SENT sid="83" pm="."><plain>The presence of the point mutation was confirmed by sequence analysis (data not shown). </plain></SENT>
</text></p><p><text><SENT sid="84" pm="."><plain>Correctly targeted ES cells bearing the point mutation were injected into mouse blastocysts, and heterozygous mtK14neo (+/mtK14neo) mice were derived. </plain></SENT>
<SENT sid="85" pm="."><plain>These mice appeared normal with no gross skin phenotypes, and histological analysis did not show microscopic blisters (data not shown). </plain></SENT>
<SENT sid="86" pm="."><plain>This was unexpected as the equivalent mutation in humans results in a dominantly inherited disease. </plain></SENT>
<SENT sid="87" pm="."><plain>We hypothesized that the lack of a phenotype in these mice was due to an interference of the neo cassette with the expression of the mutant K14 gene. </plain></SENT>
<SENT sid="88" pm="."><plain>This hypothesis was supported by semi-quantitative RT-PCR analysis that showed a twofold lower expression of mtK14neo than wild-type K14 (Fig. 2 F). </plain></SENT>
</text></p><p><text><SENT sid="89" pm="."><plain>Homozygous mtK14neo pups were normal at birth. </plain></SENT>
<SENT sid="90" pm="."><plain>However, within hours after birth, they developed extensive blisters on the front legs, paws, and chest (Fig. 2 A), and usually died within 48 h. </plain></SENT>
<SENT sid="91" pm="."><plain>Histological analysis indicated a separation within the basal cell layer of the epidermis (Fig. 2 B), which was confirmed by indirect immunofluorescent staining of K14 and integrin α6, showing an intact basement membrane (Fig. 2C and Fig. </plain></SENT>
<SENT sid="92" pm="."><plain>D). </plain></SENT>
<SENT sid="93" pm="."><plain>These results suggest that the separation occurred due to cytolysis of basal keratinocytes. </plain></SENT>
<SENT sid="94" pm="."><plain>Immunofluorescence microscopy using various differentiation markers such as keratin 10 (Fig. 2 E) and loricrin (data not shown) did not indicate any changes in the differentiation of the epidermis. </plain></SENT>
<SENT sid="95" pm="."><plain>Transmission electron microscopy revealed keratin clumps in the basal keratinocytes of lesional areas (data not shown). </plain></SENT>
<SENT sid="96" pm="."><plain>Primary keratinocytes isolated from homozygous mtK14neo pups showed a collapsed perinuclear IF network and cytoplasmic keratin aggregates when subjected to heat shock, whereas a normal IF network remained in wild-type keratinocytes under identical conditions (data not shown). </plain></SENT>
<SENT sid="97" pm="."><plain>These results are consistent with observations made in EBS-DM patients and their cultured keratinocytes (Coulombe 1993; Morley et al. </plain></SENT>
<SENT sid="98" pm="."><plain>1995; Marinkovich et al. </plain></SENT>
<SENT sid="99" pm="."><plain>1999). </plain></SENT>
</text></p><p><text><SENT sid="100" pm="."><plain>Like the previously reported K14 null mice (Lloyd et al. </plain></SENT>
<SENT sid="101" pm="."><plain>1995), the homozygous mtK14neo pups resembled a recessive form of EBS (Chan et al. </plain></SENT>
<SENT sid="102" pm="."><plain>1994; Rugg et al. </plain></SENT>
<SENT sid="103" pm="."><plain>1994; Jonkman et al. </plain></SENT>
<SENT sid="104" pm="."><plain>1996). </plain></SENT>
<SENT sid="105" pm="."><plain>However, the homozygous mtK14neo pups exhibited a more severe phenotype. </plain></SENT>
<SENT sid="106" pm="."><plain>Although some K14 null mice lived for as long as 3 mo presumably due to functional compensation by keratin 15 (Lloyd et al. </plain></SENT>
<SENT sid="107" pm="."><plain>1995), more than 95% of the homozygous mtK14neo pups died within 48 h after birth, and none lived beyond 5 d. </plain></SENT>
<SENT sid="108" pm="."><plain>This more severe phenotype is likely due to the significant amount of mutant K14 in these mice (Fig. 2C and Fig. f). </plain></SENT>
<SENT sid="109" pm="."><plain>We suspect that mutant K14 competed with the low level of keratin 15 in newborn pups for dimerization with K5, resulting in the absence of functional keratin filaments in the basal layer. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="110" pm="."><plain>Characterization of mtK14loxP Mice </plain></SENT>
</text></title><p><text><SENT sid="111" pm="."><plain>To unequivocally demonstrate that the low expression level of the mutant K14 allele led to the absence of a phenotype in +/mtK14neo mice, we deleted the neo cassette in mtK14neo ES cell clones via Cre-mediated excision (Fig. 1 A). </plain></SENT>
<SENT sid="112" pm="."><plain>Heterozygous mtK14loxP (+/mtK14loxP) pups derived from these ES cells spontaneously developed large blisters on their forelimbs and trunk (Fig. 3 A), as expected for this dominant mutation. </plain></SENT>
<SENT sid="113" pm="."><plain>Semi-quantitative RT-PCR analysis of RNA isolated from these pups showed comparable expression levels of the mutant and wild-type K14 alleles (Fig. 2 F). </plain></SENT>
<SENT sid="114" pm="."><plain>Histological analysis and immunofluorescence microscopy revealed similar findings as in the homozygous mtK14neo pups (data not shown). </plain></SENT>
</text></p><p><text><SENT sid="115" pm="."><plain>An important diagnostic feature of EBS-DM is the collapsed IF filaments revealed upon ultrastructural examination (Anton-Lamprecht and Schnyder 1982; Marinkovich et al. </plain></SENT>
<SENT sid="116" pm="."><plain>1999). </plain></SENT>
<SENT sid="117" pm="."><plain>Transmission electron microscopy showed keratin clumps in the basal keratinocytes of +/mtK14loxP pups (Fig. 3B, Fig. </plain></SENT>
<SENT sid="118" pm="."><plain>E, and Fig. </plain></SENT>
<SENT sid="119" pm="."><plain>F). </plain></SENT>
<SENT sid="120" pm="."><plain>Short IF filaments were also observed in basal keratinocytes (Fig. 3E and Fig. </plain></SENT>
<SENT sid="121" pm="."><plain>G), probably due to the significant amount of wild-type K14. </plain></SENT>
<SENT sid="122" pm="."><plain>In contrast, long IF filaments were observed in the basal keratinocytes in wild-type littermates (Fig. 3 D). </plain></SENT>
<SENT sid="123" pm="."><plain>The keratin clumps and short filaments were sometimes attached to desmosomes or hemidesmosomes, or in the perinuclear space (Fig. 3, E–G). </plain></SENT>
<SENT sid="124" pm="."><plain>Some basal cells of the mutant were vacuolated, and in the blistering areas, lymphocyte infiltration was observed (data not shown). </plain></SENT>
<SENT sid="125" pm="."><plain>The suprabasal keratinocytes appeared normal, with abundant keratin bundles and desmosomes in the spinous and granular cells (Fig. 3 C). </plain></SENT>
<SENT sid="126" pm="."><plain>Unfortunately, +/mtK14loxP pups died within a week after birth due to severe blistering. </plain></SENT>
</text></p></sec><sec><title><text><SENT sid="127" pm="."><plain>An Inducible Mouse Model for EBS </plain></SENT>
</text></title><p><text><SENT sid="128" pm="."><plain>It is important to note that although +/mtK14neo pups appeared normal, +/mtK14loxP pups with increased mutant K14 expression developed severe EBS-like phenotypes. </plain></SENT>
<SENT sid="129" pm="."><plain>These observations suggested that we might be able to generate a viable model for EBS if we could focally delete the neo cassette in +/mtK14neo mice. </plain></SENT>
</text></p><p><text><SENT sid="130" pm="."><plain>To achieve this goal, we exploited a recently developed transgenic mouse model that allows focal deletion of genomic sequences upon topical application of an inducer (Berton et al. </plain></SENT>
<SENT sid="131" pm="."><plain>2000). </plain></SENT>
<SENT sid="132" pm="."><plain>This system uses tissue-specific expression of Cre-recombinase fused to a truncated progesterone receptor (PR1) (Kellendonk et al. </plain></SENT>
<SENT sid="133" pm="."><plain>1996) under the control of an epithelial-specific promoter, such as that of K5 or K14 (Berton et al. </plain></SENT>
<SENT sid="134" pm="."><plain>2000). </plain></SENT>
<SENT sid="135" pm="."><plain>PR1 does not bind to endogenous progesterone, but binds to antiprogestin (Kellendonk et al. </plain></SENT>
<SENT sid="136" pm="."><plain>1996). </plain></SENT>
<SENT sid="137" pm="."><plain>In the absence of an antiprogestin, the CrePR1 fusion protein is expressed in the basal keratinocytes and hair follicles, but is retained in the cytoplasm and remains inactive. </plain></SENT>
<SENT sid="138" pm="."><plain>Upon topical administration of an antiprogestin, such as RU486, CrePR1 translocates to the nucleus and becomes active. </plain></SENT>
</text></p><p><text><SENT sid="139" pm="."><plain>Mice carrying the CrePR1 transgene under the control of a K5 or K14 promoter were bred with +/mtK14neo mice, and bigenic pups (mtK14neo/CrePR1) were obtained. </plain></SENT>
<SENT sid="140" pm="."><plain>RU486 (0.5 mg/ml in ethanol) was applied once daily to the forelimbs and chest of newborn pups, areas prone to mechanical trauma. </plain></SENT>
<SENT sid="141" pm="."><plain>After several (two to seven) days of RU486 treatment, we observed blisters filled with fluid on the front legs and paws of bigenic pups (Fig. 4 A). </plain></SENT>
<SENT sid="142" pm="."><plain>RU486 treatment was terminated once blisters became visible. </plain></SENT>
<SENT sid="143" pm="."><plain>Histological analysis and immunofluorescence microscopy revealed that blistering occurred within the basal layer of the epidermis, as expected (Fig. 4D and Fig. </plain></SENT>
<SENT sid="144" pm="."><plain>E). </plain></SENT>
</text></p><p><text><SENT sid="145" pm="."><plain>PCR analysis of DNA isolated from keratinocytes in the blister roof revealed the presence of the loxP site, but not the neo cassette (Fig. 4F and Fig. </plain></SENT>
<SENT sid="146" pm="."><plain>G). </plain></SENT>
<SENT sid="147" pm="."><plain>This result indicates that activation of the CrePR1 fusion protein and the subsequent excision of the neo cassette can be efficiently achieved with as few as two RU486 treatments. </plain></SENT>
<SENT sid="148" pm="."><plain>Upon termination of RU486 treatment, the induced blistered areas healed without scarring in 2 wk (Fig. 4B and Fig. </plain></SENT>
<SENT sid="149" pm="."><plain>C). </plain></SENT>
<SENT sid="150" pm="."><plain>No additional blisters formed without further RU486 treatment. </plain></SENT>
<SENT sid="151" pm="."><plain>When we dissected the healed area 1 wk after blister formation and extracted DNA from epidermal cells under the scab, isolated by laser capture microdissection, the presence of the neo cassette was detected (Fig. 4 G). </plain></SENT>
</text></p><p><text><SENT sid="152" pm="."><plain>It is possible that CrePR1 was only activated in the nonstem cell population of basal keratinocytes (transit amplifying cells) in the blistered area. </plain></SENT>
<SENT sid="153" pm="."><plain>Although blisters were induced through cytolysis of these cells, the stem cells were not targeted, i.e., they retained the neo cassette and repopulated the area after 7 d. </plain></SENT>
<SENT sid="154" pm="."><plain>However, this is not likely the case based on observations in the accompanying manuscript (Arin et al. </plain></SENT>
<SENT sid="155" pm="."><plain>2001), where the same inducible system was used to develop a mouse model for EHK. </plain></SENT>
<SENT sid="156" pm="."><plain>In the EHK mouse model, lesions develop in the suprabasal keratinocytes although the basal cells (including the stem cells) remain normal. </plain></SENT>
<SENT sid="157" pm="."><plain>Unlike our EBS lesions, induced EHK lesions persist, to date for 6 mo. </plain></SENT>
<SENT sid="158" pm="."><plain>Because the normal turnover time for mouse epidermis is ∼8–10 d (Potten et al. </plain></SENT>
<SENT sid="159" pm="."><plain>1987), this result clearly shows that epidermal stem cells are targeted by our inducible system. </plain></SENT>
<SENT sid="160" pm="."><plain>Therefore, the presence of mtK14neo allele in the healed area is best explained by migration and reepithelialization by nonphenotypic mtK14neo stem cells or transit amplifying cells derived from these stem cells from the untreated surrounding area. </plain></SENT>
<SENT sid="161" pm="."><plain>Healing of the induced blisters and the absence of recurrent lesions have significant implications for gene therapy of EBS, as defective stem cells may be replaced by nonphenotypic stem cells. </plain></SENT>
</text></p><p><text><SENT sid="162" pm="."><plain>Interestingly, although mosaic forms of EHK have been described (Paller et al. </plain></SENT>
<SENT sid="163" pm="."><plain>1994), a mosaic form of EBS has never been reported. </plain></SENT>
<SENT sid="164" pm="."><plain>Mosaic forms of EHK probably arise through postzygotic mutations, and the distribution of affected epidermis reflects migration and proliferation of mutant epidermal stem cells (Paller et al. </plain></SENT>
<SENT sid="165" pm="."><plain>1994). </plain></SENT>
<SENT sid="166" pm="."><plain>To explain the absence of mosaic forms of EBS, it is tempting to speculate that when postzygotic mutations occur in K5 or K14, the epidermal stem cells carrying the mutation would have a selective disadvantage and be rapidly displaced by wild-type stem cells. </plain></SENT>
<SENT sid="167" pm="."><plain>Consistent with the clinical observations, focal lesions were observed in chimeric EHK mice derived from +/mutloxP ES cells (Arin et al. </plain></SENT>
<SENT sid="168" pm="."><plain>2001), but not in chimeric +/mtK14loxP mice. </plain></SENT>
</text></p><p><text><SENT sid="169" pm="."><plain>Our inducible transgenic mouse model (mtK14neo/CrePR1) allows focal induction of EBS phenotypes while the mice remain viable. </plain></SENT>
<SENT sid="170" pm="."><plain>Thus, it is ideally suited to test gene therapy approaches for EBS-DM in vivo. </plain></SENT>
<SENT sid="171" pm="."><plain>Chimeric RNA–DNA oligonucleotides could be used to correct the point mutation in the mutant K14 allele through homologous recombination and mismatch repair (Cole-Strauss et al. </plain></SENT>
<SENT sid="172" pm="."><plain>1996; Alexeev et al. </plain></SENT>
<SENT sid="173" pm="."><plain>2000). </plain></SENT>
<SENT sid="174" pm="."><plain>Alternatively, the fact that +/mtK14neo mice expressed low levels of mutant K14 but had morphologically normal and functional skin suggests that the EBS phenotype may be corrected by increasing the ratio of wild-type versus mutant K14. </plain></SENT>
<SENT sid="175" pm="."><plain>This could be achieved by either increasing the expression of the wild-type K14 or partial suppression of the mutant K14 allele. </plain></SENT>
</text></p></sec></sec></SecTag></body><back><SecTag type="ACK_FUND"><ack><p><text4fund><text><SENT sid="176" pm="."><plain>We are grateful to Richard R. </plain></SENT>
<SENT sid="177" pm="."><plain>Behringer and Yuji Mishina for the PGKneobpA plasmid and Steve O'Gorman for the CMV-Cre plasmid. </plain></SENT>
<SENT sid="178" pm="."><plain>We would like to thank Richard R. </plain></SENT>
<SENT sid="179" pm="."><plain>Behringer, Yuji Mishina, Benny Chan, Guangbin Luo, and members of the Roop laboratory, especially Peter J. </plain></SENT>
<SENT sid="180" pm="."><plain>Koch, for their suggestions during the development of this project and Donna Wang and Olga Shuhatovich for technical assistance. </plain></SENT>
<SENT sid="181" pm="."><plain>We thank Francisco DeMayo for ES cell injections, Hank P. </plain></SENT>
<SENT sid="182" pm="."><plain>Adams for electron microscopy, and Craig Allred for use of the PixCell I LCM equipment. </plain></SENT>
<SENT sid="183" pm="."><plain>T. </plain></SENT>
<SENT sid="184" pm="."><plain>Cao would like to thank Anika J. and Athula H. </plain></SENT>
<SENT sid="185" pm="."><plain>Wikramanayake for their support. </plain></SENT>
</text></text4fund></p><p><text4fund><text><SENT sid="186" pm="."><plain>This work was supported by grants AR62228 from the National Institutes of Health and the Dystrophic Epidermolysis Bullosa Research Association of America to D.R. </plain></SENT>
<SENT sid="187" pm="."><plain>Roop. </plain></SENT>
</text></text4fund></p></ack></SecTag><fn-group><fn><p><text><SENT sid="188" pm="."><plain>Abbreviations used in this paper: EBS, epidermolysis bullosa simplex; EBS-DM, Dowling-Meara variant of EBS; ES, embryonic stem; EHK, epidermolytic hyperkeratosis; IF, intermediate filament; neo, neomycin. </plain></SENT>
</text></p></fn></fn-group><SecTag type="REF"><ref-list><ref id="Alexeevetal2000"><text><SENT sid="189" pm="."><plain> AlexeevV.IgouchevaO.DomashenkoA.CotsarelisG.YoonK. Localized in vivo genotypic and phenotypic correction of the albino mutation in skin by RNA-DNA oligonucleotide Nat. </plain></SENT>
<SENT sid="190" pm="."><plain>Biotechnol. 18 2000 43 47 <?supplied-pmid 10625389?>10625389 </plain></SENT>
</text></ref><ref id="Anton-LamprechtandSchnyder1982"><text><SENT sid="191" pm="."><plain> Anton-LamprechtI.SchnyderU.W. Epidermolysis bullosa herpetiformis Dowling-Meara. </plain></SENT>
<SENT sid="192" pm="."><plain>Report of a case and pathomorphogenesis Dermatologica. 164 1982 221 235 <?supplied-pmid 7084543?>7084543 </plain></SENT>
</text></ref><ref id="Arinetal2001"><text><SENT sid="193" pm="."><plain> ArinM.J.LongleyM.A.WangX.-J.RoopD.R. Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders J. </plain></SENT>
<SENT sid="194" pm="."><plain>Cell Biol. 152 2001 645 649 <?supplied-pmid 11157989?>11157989 </plain></SENT>
</text></ref><ref id="Bertonetal2000"><text><SENT sid="195" pm="."><plain> BertonT.R.WangX.J.ZhouZ.KellendonkC.SchutzG.TsaiS.RoopD.R. Characterization of an inducible, epidermal-specific knockout systemdifferential expression of lacZ in different Cre reporter mouse strains Genesis. 26 2000 160 161 <?supplied-pmid 10686618?>10686618 </plain></SENT>
</text></ref><ref id="Chanetal1994"><text><SENT sid="196" pm="."><plain> ChanY.Anton-LamprechtI.YuQ.C.JackelA.ZabelB.ErnstJ.P.FuchsE. A human keratin 14 “knockout”the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein Genes Dev. 8 1994 2574 2587 <?supplied-pmid 7525408?>7525408 </plain></SENT>
</text></ref><ref id="Chenetal1995"><text><SENT sid="197" pm="."><plain> ChenH.BonifasJ.M.MatsumuraK.IkedaS.LeydenW.A.EpsteinE.H.Jr. Keratin 14 gene mutations in patients with epidermolysis bullosa simplex J. </plain></SENT>
<SENT sid="198" pm="."><plain>Invest. </plain></SENT>
<SENT sid="199" pm="."><plain>Dermatol. 105 1995 629 632 <?supplied-pmid 7561171?>7561171 </plain></SENT>
</text></ref><ref id="Cole-Straussetal1996"><text><SENT sid="200" pm="."><plain> Cole-StraussA.YoonK.XiangY.ByrneB.C.RiceM.C.GrynJ.HollomanW.K.KmiecE.B. Correction of the mutation responsible for sickle cell anemia by an RNA-DNA oligonucleotide Science. 273 1996 1386 1389 <?supplied-pmid 8703073?>8703073 </plain></SENT>
</text></ref><ref id="Coulombe1993"><text><SENT sid="201" pm="."><plain> CoulombeP.A. The cellular and molecular biology of keratinsbeginning a new era Curr. </plain></SENT>
<SENT sid="202" pm="."><plain>Opin. </plain></SENT>
<SENT sid="203" pm="."><plain>Cell Biol. 5 1993 17 29 <?supplied-pmid 7680567?>7680567 </plain></SENT>
</text></ref><ref id="DowlingandMeara1954"><text><SENT sid="204" pm="."><plain> DowlingG.B.MearaR.H. Epidermolysis bullosa dermatitis herpetiformis Br. </plain></SENT>
<SENT sid="205" pm="."><plain>J. </plain></SENT>
<SENT sid="206" pm="."><plain>Dermatol. 66 1954 139 143 <?supplied-pmid 13149726?>13149726 </plain></SENT>
</text></ref><ref id="HatzfeldandWeber1990"><text><SENT sid="207" pm="."><plain> HatzfeldM.WeberK. The coiled coil of in vitro assembled keratin filaments is a heterodimer of type I and II keratinsuse of site-specific mutagenesis and recombinant protein expression J. </plain></SENT>
<SENT sid="208" pm="."><plain>Cell Biol. 110 1990 1199 1210 <?supplied-pmid 1691189?>1691189 </plain></SENT>
</text></ref><ref id="Jonkmanetal1996"><text><SENT sid="209" pm="."><plain> JonkmanM.F.HeeresK.PasH.H.van LuynM.J.ElemaJ.D.CordenL.D.SmithF.J.McLeanW.H.RamaekersF.C.BurtonM.SchefferH. Effects of keratin 14 ablation on the clinical and cellular phenotype in a kindred with recessive epidermolysis bullosa simplex J. </plain></SENT>
<SENT sid="210" pm="."><plain>Invest. </plain></SENT>
<SENT sid="211" pm="."><plain>Dermatol. 107 1996 764 769 <?supplied-pmid 8875963?>8875963 </plain></SENT>
</text></ref><ref id="Kellendonketal1996"><text><SENT sid="212" pm="."><plain> KellendonkC.TroncheF.MonaghanA.P.AngrandP.O.StewartF.SchutzG. Regulation of Cre recombinase activity by the synthetic steroid RU 486 Nucleic Acids Res. 24 1996 1404 1411 <?supplied-pmid 8628671?>8628671 </plain></SENT>
</text></ref><ref id="Letaietal1993"><text><SENT sid="213" pm="."><plain> LetaiA.CoulombeP.A.McCormickM.B.YuQ.C.HuttonE.FuchsE. Disease severity correlates with position of keratin point mutations in patients with epidermolysis bullosa simplex Proc. </plain></SENT>
<SENT sid="214" pm="."><plain>Natl. </plain></SENT>
<SENT sid="215" pm="."><plain>Acad. </plain></SENT>
<SENT sid="216" pm="."><plain>Sci. </plain></SENT>
<SENT sid="217" pm="."><plain>USA. 90 1993 3197 3201 <?supplied-pmid 7682695?>7682695 </plain></SENT>
</text></ref><ref id="Lloydetal1995"><text><SENT sid="218" pm="."><plain> LloydC.YuQ.C.ChengJ.TurksenK.DegensteinL.HuttonE.FuchsE. The basal keratin network of stratified squamous epitheliadefining K15 function in the absence of K14 J. </plain></SENT>
<SENT sid="219" pm="."><plain>Cell Biol. 129 1995 1329 1344 <?supplied-pmid 7539810?>7539810 </plain></SENT>
</text></ref><ref id="Marinkovichetal1999"><text><SENT sid="220" pm="."><plain> MarinkovichM.P.HerronG.S.KhavariP.A.BauerE.A. Hereditary epidermolysis bullosa FreedbergI.M.EisenA.Z.WolffK.AustenK.F.GoldsmithL.A.KatzS.I.FitzpatrickT.B. Fitzpatrick's dermatology in general medicine 1999 690 702 McGraw-Hill Co New York  </plain></SENT>
</text></ref><ref id="McGrathetal1992"><text><SENT sid="221" pm="."><plain> McGrathJ.A.Ishida-YamamotoA.TidmanM.J.HeagertyA.H.SchofieldO.M.EadyR.A. Epidermolysis bullosa simplex (Dowling-Meara). </plain></SENT>
<SENT sid="222" pm="."><plain>A clinicopathological review Br. </plain></SENT>
<SENT sid="223" pm="."><plain>J. </plain></SENT>
<SENT sid="224" pm="."><plain>Dermatol. 126 1992 421 430 <?supplied-pmid 1610681?>1610681 </plain></SENT>
</text></ref><ref id="Molletal1982"><text><SENT sid="225" pm="."><plain> MollR.FrankeW.W.SchillerD.L.GeigerB.KreplerR. The catalog of human cytokeratinspatterns of expression in normal epithelia, tumors and cultured cells Cell. 31 1982 11 24 <?supplied-pmid 6186379?>6186379 </plain></SENT>
</text></ref><ref id="Morleyetal1995"><text><SENT sid="226" pm="."><plain> MorleyS.M.DundasS.R.JamesJ.L.GuptaT.BrownR.A.SextonC.J.NavsariaH.A.LeighI.M.LaneE.B. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients J. </plain></SENT>
<SENT sid="227" pm="."><plain>Cell Sci. 108 1995 3463 3471 <?supplied-pmid 8586658?>8586658 </plain></SENT>
</text></ref><ref id="Palleretal1994"><text><SENT sid="228" pm="."><plain> PallerA.S.SyderA.J.ChanY.M.YuQ.C.HuttonE.TadiniG.FuchsE. Genetic and clinical mosaicism in a type of epidermal nevus N. </plain></SENT>
<SENT sid="229" pm="."><plain>Engl. </plain></SENT>
<SENT sid="230" pm="."><plain>J. </plain></SENT>
<SENT sid="231" pm="."><plain>Med. 331 1994 1408 1415 <?supplied-pmid 7526210?>7526210 </plain></SENT>
</text></ref><ref id="Pottenetal1987"><text><SENT sid="232" pm="."><plain> PottenC.S.SaffhillR.MaibachH.I. Measurement of the transit time for cells through the epidermis and stratum corneum of the mouse and guinea-pig Cell Tissue Kinet. 20 1987 461 472 <?supplied-pmid 3450396?>3450396 </plain></SENT>
</text></ref><ref id="Quinlanetal1985"><text><SENT sid="233" pm="."><plain> QuinlanR.A.SchillerD.L.HatzfeldM.AchtstatterT.MollR.JorcanoJ.L.MaginT.M.FrankeW.W. Patterns of expression and organization of cytokeratin intermediate filaments Ann. </plain></SENT>
<SENT sid="234" pm="."><plain>NY Acad. </plain></SENT>
<SENT sid="235" pm="."><plain>Sci. 455 1985 282 306 <?supplied-pmid 2417517?>2417517 </plain></SENT>
</text></ref><ref id="RothnagelandRoop1995"><text><SENT sid="236" pm="."><plain> RothnagelJ.A.RoopD.R. Analysis, diagnosis, and molecular genetics of keratin disorders Current Opininon in Dermatology 1995 1995 211 218  </plain></SENT>
</text></ref><ref id="Ruggetal1994"><text><SENT sid="237" pm="."><plain> RuggE.L.McLeanW.H.LaneE.B.PiteraR.McMillanJ.R.Dopping-HepenstalP.J.NavsariaH.A.LeighI.M.EadyR.A. A functional “knockout” of human keratin 14 Genes Dev. 8 1994 2563 2573 <?supplied-pmid 7525407?>7525407 </plain></SENT>
</text></ref><ref id="Steinert1990"><text><SENT sid="238" pm="."><plain> SteinertP.M. The two-chain coiled-coil molecule of native epidermal keratin intermediate filaments is a type I-type II heterodimer J. </plain></SENT>
<SENT sid="239" pm="."><plain>Biol. </plain></SENT>
<SENT sid="240" pm="."><plain>Chem. 265 1990 8766 8774 <?supplied-pmid 1692836?>1692836 </plain></SENT>
</text></ref><ref id="SteinertandRoop1988"><text><SENT sid="241" pm="."><plain> SteinertP.M.RoopD.R. Molecular and cellular biology of intermediate filaments Annu. </plain></SENT>
<SENT sid="242" pm="."><plain>Rev. </plain></SENT>
<SENT sid="243" pm="."><plain>Biochem. 57 1988 593 625 <?supplied-pmid 3052284?>3052284 </plain></SENT>
</text></ref><ref id="Vassaretal1991"><text><SENT sid="244" pm="."><plain> VassarR.CoulombeP.A.DegensteinL.AlbersK.FuchsE. Mutant keratin expression in transgenic mice causes marked abnormalities resembling a human genetic skin disease Cell. 64 1991 365 380 <?supplied-pmid 1703046?>1703046 </plain></SENT>
</text></ref><ref id="Wangetal1995"><text><SENT sid="245" pm="."><plain> WangX.J.GreenhalghD.A.LuX.R.BickenbachJ.R.RoopD.R. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas Oncogene. 10 1995 279 289 <?supplied-pmid 7530825?>7530825 </plain></SENT>
</text></ref><ref id="Wojciketal2000"><text><SENT sid="246" pm="."><plain> WojcikS.M.BundmanD.S.RoopD.R. Delayed wound healing in keratin 6a knockout mice Mol. </plain></SENT>
<SENT sid="247" pm="."><plain>Cell Biol. 20 2000 5248 5255 <?supplied-pmid 10866680?>10866680 </plain></SENT>
</text></ref></ref-list></SecTag></back><floats-group><SecTag type="FIG"><fig id="F1" position="float"><label>Figure 1</label><caption><p><text><SENT sid="248" pm="."><plain>Targeting strategy and Southern blot analysis. </plain></SENT>
<SENT sid="249" pm="."><plain>(A) Targeting strategy. </plain></SENT>
<SENT sid="250" pm="."><plain>Open boxes represent the exons. </plain></SENT>
<SENT sid="251" pm="."><plain>The asterisk denotes the C→T point mutation, and neo denotes the neomycin-resistance selection cassette. </plain></SENT>
<SENT sid="252" pm="."><plain>(B) Southern blot analysis of EcoRV-digested genomic DNA. </plain></SENT>
<SENT sid="253" pm="."><plain>The 5′ external probe (A) hybridized to an 11.7-kb fragment from the wild-type K14 locus, and a 5.5-kb fragment from the mtK14neo locus. </plain></SENT>
<SENT sid="254" pm="."><plain>The 3′ external probe (A) hybridized to the same 11.7-kb fragment from the wild-type K14 locus, and an 8.0-kb fragment from the mtK14neo locus. het., heterozygote; homo., homozygote. </plain></SENT>
</text></p></caption><graphic xlink:href="JCB0010103.f1"/></fig></SecTag><SecTag type="FIG"><fig id="F4" position="float"><label>Figure 4</label><caption><p><text><SENT sid="255" pm="."><plain>Induction and characterization of RU486 induced blisters. </plain></SENT>
<SENT sid="256" pm="."><plain>(A) Gross phenotype of an induced blister on a mtK14neo/CrePR1 pup after two RU486 treatments on the right front leg. </plain></SENT>
<SENT sid="257" pm="."><plain>No blisters developed on the untreated leg (A) or in +/mtK14neo or CrePR1 control pups treated with RU486 (data not shown). </plain></SENT>
<SENT sid="258" pm="."><plain>(B) The right front paw of a mtK14neo/CrePR1 pup 10 d after blister formation upon treatment. </plain></SENT>
<SENT sid="259" pm="."><plain>(C) The left front paw and leg of a mtK14neo/CrePR1 mouse 6 mo after blister formation and cessation of RU486 treatment. </plain></SENT>
<SENT sid="260" pm="."><plain>The blistered area, including the palm and leg, healed without scarring, and there is normal hair growth on the leg. </plain></SENT>
<SENT sid="261" pm="."><plain>No additional blisters formed without further RU486 treatment. </plain></SENT>
<SENT sid="262" pm="."><plain>(D and E) H&amp;E staining (D) and immunofluorescence microscopy with an anti-K14 antibody (Texas red, E) of an induced blister edge. </plain></SENT>
<SENT sid="263" pm="."><plain>Blistering occurred in the basal keratinocytes (arrowheads) on the chest (D and E), front leg, and paw (data not shown). </plain></SENT>
<SENT sid="264" pm="."><plain>The asterisk denotes cytolysis, and dashed lines outline the hair follicles. </plain></SENT>
<SENT sid="265" pm="."><plain>(F and G) PCR analysis of DNA for the presence of the loxP site (F) and neo cassette (G). </plain></SENT>
<SENT sid="266" pm="."><plain>(1–3) Epidermal DNA samples from different areas of a treated mtK14neo/CrePR1 pup. </plain></SENT>
<SENT sid="267" pm="."><plain>(1) Untreated area; (2) blister roof; (3) healed blistered area 1 wk after blister formation. </plain></SENT>
<SENT sid="268" pm="."><plain>(4–6) DNA samples from control mice. </plain></SENT>
<SENT sid="269" pm="."><plain>(4) Wild type; (5) +/mtK14loxP; (6) +/mtK14neo. </plain></SENT>
</text></p></caption><graphic xlink:href="JCB0010103.f4ae"/><graphic xlink:href="JCB0010103.f4fg"/></fig></SecTag><SecTag type="FIG"><fig id="F2" position="float"><label>Figure 2</label><caption><p><text><SENT sid="270" pm="."><plain>Phenotype of homozygous mtK14neo pups. </plain></SENT>
<SENT sid="271" pm="."><plain>(A) Gross phenotype of a 1-d-old pup, showing severe blisters on the front legs, paws, and chest. </plain></SENT>
<SENT sid="272" pm="."><plain>(B) H&amp;E staining of skin from a homozygous mtK14neo pup. </plain></SENT>
<SENT sid="273" pm="."><plain>The separation occurred in the basal cell layer within the epidermis. </plain></SENT>
<SENT sid="274" pm="."><plain>(C–E) Immunofluorescence microscopy of pup skin. </plain></SENT>
<SENT sid="275" pm="."><plain>The sections were stained for mutant K14 (Texas red, C–E), integrin α6 (FITC, D), and keratin 10 (FITC, E). </plain></SENT>
<SENT sid="276" pm="."><plain>Overlapping of K14 staining with either integrin α6 (D) or keratin 10 (E) results in yellow fluorescence. </plain></SENT>
<SENT sid="277" pm="."><plain>(F) AciI digestion of semi-quantitative RT-PCR products from mouse RNA. </plain></SENT>
<SENT sid="278" pm="."><plain>(1) Wild type; (2) homozygous mtK14neo; (3 and 4) +/mtK14neo; (5) +/mtK14loxP. </plain></SENT>
<SENT sid="279" pm="."><plain>Note the lower expression levels of mtK14neo allele in +/mtK14neo mice shown in lanes 3 and 4. </plain></SENT>
</text></p></caption><graphic xlink:href="JCB0010103.f2ae"/><graphic xlink:href="JCB0010103.f2f"/></fig></SecTag><SecTag type="FIG"><fig id="F3" position="float"><label>Figure 3</label><caption><p><text><SENT sid="280" pm="."><plain>Phenotype of +/mtK14loxP pups. </plain></SENT>
<SENT sid="281" pm="."><plain>(A) Gross phenotype of a 2-d-old pup, showing blisters on the left front leg and abdomen. </plain></SENT>
<SENT sid="282" pm="."><plain>(B–G) Transmission electron microscopy of skin samples from +/mtK14loxP pups (B, C, and E–G) and normal littermate (D). </plain></SENT>
<SENT sid="283" pm="."><plain>The mtK14loxP pup skin showed keratin clumps and short keratin filaments in the basal keratinocytes (B, E–G), but normal keratin filaments in the suprabasal layer of the epidermis (B and C). </plain></SENT>
<SENT sid="284" pm="."><plain>Normal skin showed long keratin filaments in the basal keratinocytes (D). </plain></SENT>
<SENT sid="285" pm="."><plain>Kc, keratin clumps; Kf, keratin filaments; Kg, keratohyalin granules; Nu, nucleus. </plain></SENT>
<SENT sid="286" pm="."><plain>Small arrowheads denote hemidesmosomes, indicating the position of the basement membrane. </plain></SENT>
<SENT sid="287" pm="."><plain>Large arrowheads denote desmosomes. </plain></SENT>
<SENT sid="288" pm="."><plain>Bars: (B) 5 μm; (C) 100 nm; (D–G) 1 μm. </plain></SENT>
</text></p></caption><graphic xlink:href="JCB0010103.f3a"/><graphic xlink:href="JCB0010103.f3bg"/></fig></SecTag></floats-group></article>
